Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation

Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation

Background: We sought to determine whether leucine zipper protein 2 (LUZP2) could benefit men with prostate cancer (PCa) undergoing radical radiotherapy (RT) or prostatectomy (RP). Methods: Analysis was done on differentiating expression, clinical prognosis, co-expressed genes, immune infiltration,...

Full description

Bibliographic Details
Main Authors: Dechao Feng, Weizhen Zhu, Xu Shi, Wuran Wei, Ping Han, Qiang Wei, Lu Yang
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Heliyon
Subjects:
Prostate cancer
Senescence
Tumor immune environment
RNA modification
DNA methylation
Leucine zipper protein 2
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844022020382

Internet

http://www.sciencedirect.com/science/article/pii/S2405844022020382

Similar Items